Examples of using Pharmacokinetic interaction in English and their translations into Polish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
No interaction study between INVEGA and lithium has been performed, however, a pharmacokinetic interaction is unlikely to occur.
there was no pharmacokinetic interaction.
there was no pharmacokinetic interaction.
In vitro and clinical pharmacokinetic interaction studies have shown the potential for CYP-mediated interactions involving emtricitabine and tenofovir disoproxil fumarate
In vitro and clinical pharmacokinetic interaction studies have shown the potential for CYP450 mediated interactions involving emtricitabine
The pharmacokinetic interaction of Pelzont with statins has been studied only with simvastatin see section 4.4.
In the absence of pharmacokinetic interaction studies, alli is not recommended to be used by patients receiving acarbose.
Pharmacokinetic interaction studies in postmenopausal women have demonstrated the absence of any interaction potential with tamoxifen or hormone replacement therapy oestrogen.
In patients with rheumatoid arthritis, no pharmacokinetic interaction between the leflunomide(10 to 20 mg per day)
On average, the sirolimus dose will need to be 4-fold higher to account for both the absence of the pharmacokinetic interaction(2-fold increase)
due to a marked pharmacokinetic interaction(76% decrease of etravirine AUC) that could significantly
A pharmacokinetic interaction between vinflunine and pegylated/liposomal doxorubicin was observed,
A study in healthy subjects with eslicarbazepine acetate 1,200 mg once daily showed a minor average pharmacokinetic interaction(exposure of lamotrigine decreased 15%) between eslicarbazepine acetate
due to a marked pharmacokinetic interaction(76% decrease of etravirine AUC) that could significantly
Due to the pharmacokinetic interaction and possible pharmacodynamic interaction, calcium antagonists with
In patients taking medicinal products where the pharmacokinetic interaction with lamotrigine is currently not known(see section 4.5),
on binding affinity between sugammadex and other medicinal products, non-clinical experiments and simulations using a model taking into account the pharmacodynamic effect of neuromuscular blocking agents and the pharmacokinetic interaction between neuromuscular blocking agents and sugammadex.
other medicinal products, non-clinical experiments, clinical studies and simulations using a model taking into account the pharmacodynamic effect of neuromuscular blocking agents and the pharmacokinetic interaction between neuromuscular blocking agents and sugammadex.
Given the pharmacokinetic interaction between Kaletra and tenofovir(see section 4.5),
did not show a pharmacokinetic interaction but a relevant increase in bleeding time was observed in a subset of patients which was not correlated to platelet aggregation,